Effect of tremorigenic agents on the cerebellum: a review of biochemical and electrophysiological data.
Longo
V G
VG
Massotti
M
M
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D002529:Cerebellar Nuclei / Q000503:physiopathology; D002531:Cerebellum / Q000032:analysis / Q000187:drug effects*; D006152:Cyclic GMP / Q000032:analysis; D003975:Diazepam / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004569:Electroencephalography; D006246:Harmaline / Q000494:pharmacology*; D006247:Harmine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology; D008526:Medulla Oblongata / Q000503:physiopathology; D009434:Neural Pathways / Q000187:drug effects; D009847:Olivary Nucleus / Q000187:drug effects / Q000503:physiopathology; D011817:Rabbits; D013116:Spinal Cord / Q000503:physiopathology; D009435:Synaptic Transmission / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced* / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000470:Alkaloids; D007980:Levodopa; D006247:Harmine; D005680:gamma-Aminobutyric Acid; D006246:Harmaline; D006152:Cyclic GMP; D003975:Diazepam; D004298:Dopamine